Does drug promotion adversely influence doctors’ abilities to make the best decisions for patients?
✍ Scribed by Jon Jureidini; Peter Mansfield
- Publisher
- Informa plc
- Year
- 2001
- Tongue
- English
- Weight
- 101 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1039-8562
No coin nor oath required. For personal study only.
✦ Synopsis
Aim: To increase awareness amongst psychiatrists and trainees of the effects of pharmaceutical promotion and to stimulate careful evaluation of the relationships between psychiatry and the pharmaceutical industry.
Method: Key findings from the literature and from 20 years experience with the Medical Lobby for Appropriate Marketing are summarised.
Results: The relationship between doctors and pharmaceutical companies is shown to be problematic in a way that might negatively impact on patient care.
Conclusions: Patients may benefit if individual psychiatrists, and the profession as a whole, develop more healthy scepticism about the harm to benefit ratios of relationships with the pharmaceutical industry.